Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3726826013 | Antidiabetic therapeutic role (role) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3726827016 | Antidiabetic therapeutic role | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Antidiabetic therapeutic role | Is a | Therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Antidiabetic agent | Plays role | True | Antidiabetic therapeutic role | Inferred relationship | Some | |
| Dapagliflozin- and metformin- and saxagliptin-containing product | Plays role | True | Antidiabetic therapeutic role | Inferred relationship | Some | |
| Dapagliflozin and metformin and saxagliptin only product | Plays role | True | Antidiabetic therapeutic role | Inferred relationship | Some | |
| Dapagliflozin and metformin and saxagliptin only product in oral dose form | Plays role | True | Antidiabetic therapeutic role | Inferred relationship | Some | |
| Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form | Plays role | True | Antidiabetic therapeutic role | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
Australian dialect reference set
Description inactivation indicator reference set
FHIR